拱东医疗的前世今生：2025年三季度营收8.45亿行业排23，净利润7189万排29

Core Viewpoint - Gongdong Medical is a leading manufacturer of disposable medical consumables in China, with advanced production technology and strict quality control systems [1] Group 1: Business Overview - Gongdong Medical was established on August 17, 2009, and was listed on the Shanghai Stock Exchange on September 16, 2020 [1] - The company focuses on the research, production, and sales of disposable medical consumables, categorized under the pharmaceutical and biological industry, specifically in medical devices and consumables [1] Group 2: Financial Performance - For Q3 2025, Gongdong Medical reported revenue of 845 million, ranking 23rd among 50 companies in the industry [2] - The industry leader, Yingke Medical, reported revenue of 7.425 billion, while the second, Guoke Hengtai, reported 5.353 billion; the industry average revenue was 1.379 billion, and the median was 755 million [2] - The company's net profit for the same period was 71.89 million, ranking 29th in the industry [2] - The top net profit earners were Lepu Medical at 999.6 million and Yingke Medical at 952 million, with the industry average at 183 million and the median at 75.88 million [2] Group 3: Financial Ratios - As of Q3 2025, Gongdong Medical's debt-to-asset ratio was 18.49%, an increase from 15.66% year-on-year, which is lower than the industry average of 23.66%, indicating good solvency [3] - The company's gross profit margin for Q3 2025 was 30.13%, down from 33.35% year-on-year, and below the industry average of 48.78%, suggesting a need for improvement in profitability [3] Group 4: Executive Compensation - The chairman, Shi Huiyong, received a salary of 749,000 for 2024, an increase of 68,600 from 2023 [4] - The general manager, Zhong Weifeng, earned 646,900 in 2024, up by 62,300 from the previous year [4] Group 5: Shareholder Information - As of September 30, 2025, the number of A-share shareholders for Gongdong Medical increased by 17.57% to 11,600 [5] - The average number of circulating A-shares held per shareholder decreased by 14.94% to 19,000 [5]